Cheapest GLP-1 With Insurance: What You'll Actually Pay in 2026
By the Weight Loss Provider Guide editorial team — an independent comparison resource for GLP-1 telehealth providers. Last verified: 2026-05-29.
About our links: We may earn a commission if you start care through some of the providers we mention. That never changes our numbers — and as you'll see, the cheapest path for a lot of people isn't a paid provider at all. It's your own doctor. We'll tell you exactly when that's true.
The short answer (read this first)
The cheapest GLP-1 with insurance is a brand-name weight-loss GLP-1 — Wegovy (semaglutide) or Zepbound (tirzepatide) — filled through your commercial insurance with the maker's free savings card. That combo can cost as little as $25 a month. But “$25” is a floor, not a promise. It happens when three things line up: you have commercial (private or job-based) insurance, your plan actually covers the drug, and your copay is low enough for the card to absorb it.
Here's the part the ads skip. If you already have a doctor who'll write the prescription, you don't need to pay a telehealth membership to get that $25 price — you can go straight to the drugmaker and skip the fee. A paid online provider is worth it in one specific situation, and we'll show you exactly which one.
Best for
People with commercial insurance whose plan covers a weight-loss GLP-1
Not cheapest for
Plans that exclude weight-loss drugs, or anyone trying to use Ozempic/Mounjaro for weight loss — those get denied. You want Wegovy or Zepbound.
Your number, fast
~$25/mo with commercial coverage + card · ~$50/mo on new 2026 Medicare option · ~$149–$699/mo if no coverage
Start here: find your exact situation in the table just below — it's the fastest way to see your real cost.
Find Your Situation
Two questions. Get your estimated monthly cost and exact next step.
1. What kind of insurance do you have?
What is the cheapest GLP-1 with insurance?
The cheapest GLP-1 with insurance is usually the weight-loss GLP-1 your plan already covers, plus that drug's manufacturer savings card, prescribed through the lowest-cost route you can use. For people with commercial coverage, that brings Wegovy or Zepbound down to as little as $25 a month. The catch is coverage — many plans don't cover weight-loss GLP-1s, and nearly all that do require pre-approval first.
“With insurance” is not one price. Your real cost comes down to three things, in order: (1) which GLP-1 you're getting, (2) whether your specific plan covers it — the big one, and (3) what kind of insurance you have. So the smartest move isn't “find the cheapest drug.” It's “find the cheapest total path for your situation.”
Your real monthly cost, by situation
| If this is you | What you'll likely pay | What makes it cheap (or not) | Your next step |
|---|---|---|---|
| Commercial plan that covers a weight-loss GLP-1 + savings card | ~$25/mo (sometimes $0 for early Wegovy fills) | Card pays down a big chunk of your copay | Enroll in the free card, fill at your pharmacy |
| Commercial plan covers it, but your copay is high | $25 + the leftover | Card has a monthly cap; you pay anything above it | Same card; ask about a lower-tier covered option |
| You have diabetes + plan covers Ozempic/Mounjaro for diabetes | Your diabetes copay (often a low tier) | Diabetes is covered far more often than weight loss | Use the diabetes coverage you already have |
| Commercial plan that excludes weight-loss drugs | ~$149–$699 cash | The $25 copay-card path won't apply; switch to maker's self-pay | See the no-coverage section below |
| Medicare Part D (qualifies, from July 2026) | ~$50 copay | New CMS program; savings cards aren't allowed on Medicare | Have your doctor file the pre-approval — Medicare section below |
| Medicaid (in a state that covers weight loss) | $0–low copay | 13 states cover it for weight loss; rules are strict | Check your state's drug list |
| No insurance / not covered | ~$149–$699 | Buy direct from the maker (TrumpRx / LillyDirect / NovoCare) | See the no-coverage section below |
Sources: NovoCare and Eli Lilly savings terms; KFF and Ro coverage data; KFF on the 2026 Medicare program. Verified May 2026.
▶ Do you even have coverage? Find out before you spend a dollar.
You can't pick the cheapest path until you know whether your plan covers a weight-loss GLP-1. The fastest way — without sitting on hold — is a free coverage check.
Check if your plan covers a GLP-1 — free → RoAlready have a doctor and know you're covered? Skip the check and enroll in the savings card yourself — no membership needed.
Which GLP-1s can actually be $25 with insurance?
Several FDA-approved GLP-1s advertise “as low as $25” for people with commercial insurance — but the fine print differs by drug. The two built for weight loss, Wegovy and Zepbound, are the ones a weight-loss plan is most likely to cover. Ozempic and Mounjaro are diabetes drugs, so they're usually only cheap if you're treating diabetes. Foundayo is the brand-new oral option for 2026.
| GLP-1 | FDA-approved for | With commercial coverage + card | Savings card (2026) | Cash price if NOT covered | Coverage note |
|---|---|---|---|---|---|
| Wegovy (semaglutide pen) | Weight loss; heart-risk reduction | ~$25/mo (as low as $0 early on) | Up to ~$225/mo off copay | ~$199/mo intro through Jun 30 2026, then ~$349/mo (NovoCare) | Most likely weight-loss drug to be covered |
| Wegovy pill (oral semaglutide) | Weight loss | ~$25/mo if covered | Same Wegovy savings program | ~$149/mo (1.5–4 mg) up to ~$299 higher doses | Newer; coverage varies |
| Zepbound (tirzepatide pen) | Weight loss; sleep apnea | ~$25/mo | Up to ~$100/mo off copay; ~$1,300/yr cap | ~$299–$449/mo (vials or KwikPen); high doses up to ~$699 | Sleep apnea can unlock coverage |
| Foundayo (orforglipron pill) | Weight loss (approved Apr 1, 2026) | ~$25/mo if covered | Up to ~$100/mo; ~$1,000/yr cap; max 10 fills/yr | ~$149/mo starter up to ~$349 higher doses | First GLP-1 pill with no food/water timing rules |
| Ozempic (semaglutide) | Type 2 diabetes | Your diabetes copay (if diabetic) | As low as $25 if covered for diabetes | Varies (diabetes drug) | Off-label for weight loss is often denied |
| Mounjaro (tirzepatide) | Type 2 diabetes | Your diabetes copay (if diabetic) | As low as $25 for up to 3-mo fill | Varies (diabetes drug) | Same story as Ozempic |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Your diabetes copay (if diabetic) | As low as $25 (1-, 2-, 3-mo) | Varies (diabetes drug) | Off-label denials common for weight loss |
Sources: NovoCare (Wegovy, Ozempic, Rybelsus); Eli Lilly (Zepbound) and Foundayo terms; FDA approval record for Foundayo (April 1, 2026). All “as low as $25” offers are commercial-insurance only and exclude government plans. Verified May 2026.
The single most useful insight in that table
If you want the cheapest insured price, you want the drug your plan covers for weight loss — almost always Wegovy or Zepbound, not Ozempic or Mounjaro. Insurers often turn down Ozempic and Mounjaro when prescribed for weight loss, because those are approved for diabetes. Many will approve the weight-loss version instead.
How do GLP-1 savings cards work — and why isn't it always $25?
A manufacturer savings card (also called a copay card) is not insurance and not a coupon — it works on top of your commercial insurance and pays down part of your copay, up to a monthly limit. You hit the famous “$25” only if your copay is low enough for the card's monthly cap to cover the rest. If your copay is higher, you pay the difference.
What you'll actually pay after the card (Zepbound example — card pays up to $100/mo)
| Your copay before the card | You pay | Why |
|---|---|---|
| $25 or less | Your copay (≤$25) | You're already at or below the floor |
| $80 | $25 | Card covers the rest down to the $25 floor |
| $125 | $25 | Card's $100 cap brings you right to $25 |
| $175 | $75 | Card pays its $100 max; you pay the $75 over |
| $300 | $200 | Card pays $100; you pay the rest |
How much the card covers depends on the drug: Wegovy's card pays up to about $225/month of your copay; Zepbound's pays up to $100/month (~$1,300/year); Foundayo's pays up to $100/month (~$1,000/year, max 10 fills). Your floor is $25 if your copay fits under the cap.
Rules worth burning into memory:
- The card needs your plan to cover the drug. No coverage means the card can't apply, and you move to cash prices.
- You can't use any savings card with Medicare, Medicaid, TRICARE, or VA. That's federal law.
- What the card pays doesn't count toward your deductible or your out-of-pocket max. If your plan front-loads a deductible, the $25 may not start until you've cleared it.
- Watch for “copay accumulator” or “maximizer” rules — some plans don't let coupon dollars count toward your deductible, stretching out how long you pay more.
- Enrolling is free and fast. Get the Wegovy card at NovoCare.com; the Zepbound card at zepbound.lilly.com. It takes a few minutes.
So when an ad says “as low as $25,” it's telling the truth — that's the lowest you might pay. It just isn't a guarantee. Your copay tier decides whether you land there.
Do you need an online provider, or is your own doctor cheaper?
If you already have an in-network doctor who'll prescribe the covered GLP-1 and handle the paperwork, that's usually the cheapest path — you skip every membership fee. Online providers earn their cost when you don't have that: no doctor, a denial to fight, or pre-approval paperwork you don't have time for.
Let's be honest about this, because most affiliate pages bury it.
Ro — the provider we point most insured readers to — is not the cheapest way to get a GLP-1 if you already have a willing doctor. Ro charges a membership ($39 first month, then $149/month, or as low as $74/month paid annually) that's separate from the medicine and doesn't count toward your deductible. If you've got a doctor and your plan covers the drug, go straight to NovoCare or LillyDirect, grab the free savings card, and you may pay as little as $25 a month — with no membership fee on top.
So why do thousands of insured people happily pay for Ro? Because the $149 isn't buying the drug. It's buying the system around it. Most plans that cover a weight-loss GLP-1 require pre-approval, and many want a documented BMI and proof you tried other steps first. That paperwork is exactly where people stall out or get denied. Ro's insurance concierge works with your insurer, submits the pre-approval paperwork, and explores other options if you're denied.
Here's the clean way to decide, by who you are:
- You have a doctor + your plan covers the drug → you don't need Ro. Get the savings card direct and pay as little as $25/mo.
- You have no doctor, you got denied, or the paperwork is burying you → a service like Ro earns its fee. Its team handles the insurance work.
- You're on Medicare, Medicaid, or TRICARE → Ro can't coordinate those government plans for GLP-1s (FEHB is an exception). See the Medicare section below.
The provider paths, side by side (verified May 2026)
Membership and medicine are billed separately at every one of these — that's normal for the category.
| Path | Best for | Membership / visit cost | Medicine cost | Insurance help | The catch |
|---|---|---|---|---|---|
| Your in-network doctor | You have a doctor who'll prescribe | Your normal visit copay | ~$25/mo with coverage + card | Depends on the office | Not every doctor moves fast on pre-approval |
| Ro (our pick for insurance help) | No doctor, a denial, or you want the paperwork handled | $39 first month, then $149/mo (or ~$74/mo paid annually) | Maker-matched; ~$25 copay if covered | Concierge files pre-approval + works your coverage; free coverage checker | Fee doesn't count toward deductible; no government plans (except FEHB) |
| Sesame (our pick for provider choice) | You want to pick your own provider + a wide drug menu | ~$99 every 28 days, or as low as $59/mo on an annual plan | ~$25/mo with coverage; broad cash menu | Providers help with pre-approval | Subscription is separate from medicine; 28-day billing = 13 cycles/yr |
| WeightWatchers Med+ | You want coaching + clinical care together | ~$74/mo on a 12-month plan | Medicine separate; oral Wegovy from ~$149/mo | Works with commercial insurance | No government or Kaiser plans; annual commitment |
| PlushCare | You want a regular online doctor's office | $19.99/mo membership + ~$119–$129 per visit | Depends on insurance/pharmacy | Insurance billing + pre-approval support | Costs are piecemeal; no coaching |
| Form Health | You want obesity-specialist care | Bills visits/labs/meds to insurance; $299/mo if self-pay | Through insurance when covered | Care team helps with approvals | Pricier; built for complex cases |
Sources: provider pricing pages for Ro, Sesame, WeightWatchers, PlushCare, and Form Health, verified May 2026.
The honest takeaway: for an insured shopper who wants help, Ro is the strongest first stop because of the insurance concierge and free checker. If you'd rather pick your own provider, Sesame can be the lowest all-in cost — about $59/month on an annual plan plus ~$25 medicine ≈ $84/month once your coverage is approved. And if you already have a doctor, none of these beat free.
What gets a GLP-1 approved?
| What plans commonly require | Why it matters | What gets you approved |
|---|---|---|
| Prior authorization (almost always) | No PA on file = automatic rejection at the counter | Your doctor submits the PA form before you fill |
| BMI threshold (often 30+, or 27+ with a related condition) | It's the clinical gate for weight-loss approval | A BMI recorded in your chart, usually within ~90 days |
| Step therapy (try a cheaper drug first) | Some plans want phentermine first, or a semaglutide before a tirzepatide | Document a real trial (~90 days) or a reaction that ruled it out |
| The weight-loss version of the drug | Off-label Ozempic/Mounjaro for weight loss gets denied a lot | Ask for Wegovy or Zepbound instead |
| A qualifying condition | A related diagnosis can unlock coverage | Wegovy via heart-risk reduction; Zepbound via sleep apnea |
The two highest-leverage moves to get covered cheaply:
- Ask for the weight-loss brand, not the diabetes one. If you were quoted Ozempic or Mounjaro for weight loss and denied, your doctor can request Wegovy or Zepbound — insurers approve these far more readily.
- Use a qualifying condition if you have one. Wegovy's heart-risk approval and Zepbound's sleep-apnea approval have pushed more plans to cover them. If you have either, make sure your doctor writes it down.
📋 May 2026 coverage update
CVS Caremark — which manages drug benefits for about 90 million people — said it will put Zepbound back on its standard commercial drug lists as a preferred option on October 1, 2026, and clear the way for Foundayo starting June 1, 2026. Wegovy keeps its preferred spot, and the company says covered patients will have the same copay across Lilly and Novo drugs. Whether you benefit depends on whether your employer uses CVS's standard list. Sources: Reuters; CVS Health. May 2026.
📞 Free tool: your insurance call script
Before you pick anything, call the number on your insurance card and read this:
“Can you tell me which GLP-1 medications my plan covers for weight loss — Wegovy, Zepbound, or Foundayo? Do they need prior authorization or step therapy? What's my copay, and have I met my deductible? Is there a preferred pharmacy I have to use?”
Write down the answers. That 5-minute call tells you your real number and saves you from guessing. It's the same info every provider will ask you for.
What if my prior authorization is denied?
A denial is common and often reversible. The top fixable reasons are: no pre-approval on file, BMI not documented, step therapy not met, or an off-label diabetes drug requested for weight loss. You can resubmit, switch to the weight-loss brand, document a qualifying condition, or — if your plan is dropping a drug you're already on — file a “continuation of care” request.
One reality check: about 56% of GLP-1 users told KFF the drugs were difficult to afford, including 1 in 4 who said “very difficult.” You're not doing anything wrong — the system is just clunky. Most denials are fixable.
| Denial reason | What to do next |
|---|---|
| Prior authorization needed | Have your doctor submit the PA form, then refill |
| BMI not documented | Add a recent BMI to your chart and resubmit |
| Step therapy not met | Document the cheaper-drug trial (or a reaction to it) |
| Wrong drug / off-label | Switch from Ozempic/Mounjaro to Wegovy or Zepbound |
| Weight-loss drugs excluded | Ask if a GLP-1 is covered for a condition you actually have (heart risk, sleep apnea, diabetes) |
| Your drug was dropped from the formulary | Ask your doctor to file a continuation-of-care request and send a fresh prescription so you don't get a coverage gap |
Don't go without while you fight it. Buying direct from the maker (NovoCare/LillyDirect) keeps you on treatment at cash prices, and if your coverage comes through, you switch back to the ~$25 covered price.
▶ Denied or stuck in pre-approval limbo? Hand it off.
Working a GLP-1 denial is exactly the paperwork a telehealth concierge exists for. If you don't have the time — or a doctor in your corner — let them take it.
Get help getting your GLP-1 covered → RoIs it cheaper with Medicare, Medicaid, TRICARE, or VA?
It's different — and you can't use manufacturer savings cards on any government plan. Historically, Medicare wouldn't cover weight-loss drugs at all. That's changing: a new program called the Medicare GLP-1 Bridge lets qualifying Part D members pay a flat $50 a month for certain weight-loss GLP-1s starting July 1, 2026. Medicaid coverage depends entirely on your state — only 13 states cover GLP-1s for weight loss right now.
Medicare
- For years, Medicare was legally barred from covering drugs used for weight loss.
- The Medicare GLP-1 Bridge is a short-term CMS program that covers, for weight loss, all forms of Wegovy (injection and pill), all forms of Foundayo, and the Zepbound KwikPen (not Zepbound vials or single-dose pens) at a flat $50 copay — the same $50 no matter your dose. (KFF, NPR)
- Who qualifies: enrolled in a Part D plan, and either BMI ≥35 (qualifies on its own), or BMI ≥27 plus a condition like heart disease or prediabetes. Your doctor submits a pre-approval confirming it's for weight management.
- You don't have to find a special plan. Part D plans don't opt in — your prescriber just files the pre-approval.
- The fine print: the $50 copay doesn't count toward your Part D deductible, and it doesn't count toward the $2,100 yearly out-of-pocket cap. Low-income “Extra Help” doesn't lower it either.
- When: runs July 1, 2026 through December 31, 2027.
- If a GLP-1 is prescribed for a different use — Wegovy for heart-risk reduction, or Zepbound for sleep apnea — that goes through your regular Part D coverage, not the Bridge.
Medicaid
- Coverage is state by state. As of January 2026, 13 states cover GLP-1s for weight loss — down from 16 after California, New Hampshire, Pennsylvania, and South Carolina dropped it. (KFF)
- Every state Medicaid program must cover FDA-approved drugs for medically accepted uses — including GLP-1s for type 2 diabetes, Wegovy's heart-disease use, and Zepbound's sleep-apnea use. Obesity-only coverage is the optional part.
- Where covered, expect strict rules: pre-approval, BMI thresholds, and step therapy (some states want phentermine first).
- Your move: check your state Medicaid drug list for “anti-obesity agents” and their rules.
Quick guide: government plans and GLP-1 cost
| Your coverage | Savings card? | Medicare Bridge? | Cheapest move |
|---|---|---|---|
| Medicare Part D | ❌ No | ✅ If you meet BMI rules | Have your doctor file the Bridge pre-approval (from July 2026) |
| Medicaid | ❌ No | ❌ No | Check your state's drug list; diabetes/comorbidity paths may apply |
| TRICARE / VA | ❌ No | ❌ No | Check your plan's formulary and pharmacy benefit |
| FEHB (federal employee) | ✅ Yes (it's commercial) | ❌ No | Use your coverage + savings card; you can also use Ro's concierge |
What's the cheapest GLP-1 if insurance won't cover it?
If your plan excludes weight-loss GLP-1s, the savings card can't help — you're effectively paying cash. The cheapest legitimate cash routes in 2026 are direct from the drugmaker. The government's TrumpRx.gov site is a portal that points you to those maker-direct prices.
- Wegovy pill: ~$149/mo for the 1.5 mg and 4 mg doses; the 4 mg $149 price runs through Aug 31, 2026, then becomes ~$199. Higher doses ~$299/mo (NovoCare).
- Foundayo (orforglipron): the newest GLP-1 pill; ~$149/mo to start, up to ~$349/mo at the highest doses (LillyDirect).
- Wegovy injection (NovoCare): ~$199/mo for your first two fills of the lowest doses (through June 30, 2026), then ~$349/mo.
- Zepbound (LillyDirect): vials or KwikPen from ~$299/mo (2.5 mg starter), ~$399 (5 mg), and as low as ~$449 for higher doses if you refill within the offer window; without that, higher-dose KwikPen can run up to ~$699/mo.
- TrumpRx.gov: a government portal that links you to maker-direct prices for Wegovy, Ozempic, Zepbound, and Foundayo. You buy on the maker's site; the portal just routes you there.
A clear word on compounded GLP-1s
Compounded semaglutide and tirzepatide are mixed by compounding pharmacies. They are not FDA-approved, and they are not generic versions of Wegovy, Ozempic, Zepbound, or Mounjaro — they're a different product. Their availability has been restricted since the FDA said the semaglutide and tirzepatide shortages are over. They can cost less than brand-name cash prices, but they aren't the same as an FDA-approved drug, and insurance and savings cards generally don't apply to them. If you want to understand that route, read our separate comparison.
See our full GLP-1 provider cost comparison, including compounded options →Is Ozempic cheaper than Wegovy with insurance?
Not necessarily. If both are covered and you qualify for the savings card, several brand-name GLP-1s land at a similar “as low as $25” floor. The cheaper one is whichever your plan actually covers for your diagnosis. Because Ozempic is a diabetes drug and Wegovy is a weight-loss drug, plans treat them differently — and trying to use Ozempic for weight loss often leads to a denial. Ask your insurer which one is covered for your situation, and have your doctor prescribe that one.
What real patients run into
“The savings, if covered by insurance, would be life-changing.”
— Elizabeth Kenly, 59 (Graham, NC), who told NBC News she'd been paying about $600 a month for compounded tirzepatide and could drop to as little as $25 a month if her insurance approved the brand-name drug. Source: NBC News.
We included this because it captures the exact gap this page closes — the difference between paying cash and getting the brand covered. Disclosure: this is a real, named account from NBC News reporting. It shows a cost difference, not a typical or guaranteed result, and it's not evidence about any drug's safety or how well it works. Your costs and results will vary.
How we verified and ranked these paths
We ranked by total cost, not by advertised drug price — and not by which provider pays us. A $25 drug with a $149 membership is a different number than a $25 drug through a doctor you already have. We checked manufacturer savings terms, provider pricing pages, the CMS Medicare program, Medicaid and employer coverage data from KFF, and FDA guidance on compounded drugs.
✅ What we actually verified — May 29, 2026
- Foundayo (orforglipron) is FDA-approved as a weight-loss GLP-1 pill (April 1, 2026) — confirmed via FDA records and Eli Lilly.
- Wegovy and Zepbound savings cards: commercial-insurance only, ~$25 floor, no government plans — confirmed via NovoCare and Eli Lilly.
- Ro carries Zepbound, Foundayo, the Wegovy pill and pen, and Ozempic; offers a free coverage checker and insurance concierge; membership $39 first month, then $149/mo (or ~$74/mo annually); FEHB members can join — confirmed via Ro.
- Sesame subscription ~$99/28 days (or ~$59/mo annually), medicine separate, ~$25/mo with insurance — confirmed via Sesame.
- Medicare GLP-1 Bridge: $50 flat copay; all forms of Wegovy and Foundayo plus Zepbound KwikPen; BMI 35+ or 27+ with condition; July 1, 2026 – December 31, 2027; no plan opt-in; doesn't count toward deductible or out-of-pocket cap — confirmed via KFF and NPR.
- Medicaid: 13 states cover GLP-1s for weight loss (down from 16) — confirmed via KFF.
- CVS Caremark restoring Zepbound (Oct 1, 2026) and adding Foundayo (June 1, 2026) — confirmed via Reuters and CVS Health.
- TrumpRx.gov is a portal to maker-direct prices, not a pharmacy.
How we ranked the paths
| Factor | Weight | Why it matters |
|---|---|---|
| Lowest all-in cost (after fees) | 30% | A $25 drug + $149 membership ≠ a $25 drug through your own doctor |
| FDA-approved + insurance fit | 20% | This search is about covered brand-name drugs, not compounded |
| Help getting approved | 15% | Coverage usually fails at the paperwork |
| Honest, upfront pricing | 15% | Hidden fees break trust |
| Clear on government plans | 10% | Medicare/Medicaid users need different routing |
| Real-world usability | 10% | The 'cheapest' path has to be one you can actually use |
Cheapest GLP-1 with insurance: FAQ
Related guides
- Full GLP-1 Provider Cost Comparison (brand-name + compounded)
- Cheapest Name-Brand GLP-1 in 2026: Actual Cash Prices
- Best Foundayo Providers That Accept Insurance
- Cheapest Foundayo With Insurance: 4 Paths Compared
- Foundayo vs. Zepbound: Pill vs. Shot Comparison
- GLP-1 Telehealth Safety Checklist
- Who Can Prescribe GLP-1s Online?
- Find My GLP-1 Path — free 60-second quiz
Sources
- NovoCare — Wegovy savings card terms and cash pricing
- Eli Lilly — Zepbound savings card terms and cash pricing
- Eli Lilly — Foundayo coverage and savings terms
- KFF — Medicare GLP-1 Bridge details and Medicaid coverage by state
- KFF — Medicaid GLP-1 coverage by state (13 states, Jan 2026)
- NPR — Medicare GLP-1 Bridge $50 copay details
- Reuters — CVS Caremark Zepbound formulary restoration
- CVS Health — Zepbound + Foundayo formulary announcement
- FDA — Foundayo approval record (April 1, 2026)
- NBC News — Elizabeth Kenly quote on cost difference
Still not sure where to start?
The fastest move if you have insurance: run Ro's free coverage check — it takes a few minutes and tells you exactly what your plan covers and your likely copay, before you pay anything. If you're paying cash, Sesame's annual plan has the lowest fee we found among established managed programs.
Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission from some provider links, which never changes our analysis or who we call cheapest. Content is informational only and is not medical advice. Prices, coverage rules, and formulary status change frequently — last verified 2026-05-29. Always confirm details directly with your insurer or the manufacturer before ordering.